Monthly Archives: March 2022

Our review on high-dose vitamin C as multi-targeting anti-cancer agent: highly down-loaded in 2021

  • March 26, 2022
  • Comments off

The Journal of Experimental & Clinical Cancer Research (JECCR) has congratulated Connie Jimenez on authoring one of the most-downloaded papers published in the journal during 2021 (‘High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer’). Since publishing, the article has been downloaded 3144 times. Go see the article

Read More

Phosphoproteomics identifies new therapies for T-cell acute lymphoblastic leukemia

  • March 14, 2022
  • Comments off

Our study published Feb. 25 in Nature Communications shows that phosphoproteomic profiling can discover novel targets for therapy for T-ALL and it can guide the design of treatment combination strategies when a single therapy is not sufficient. The analysis of active proteins gives us a more complete picture of the leukemia and allows for selection […]

Read More